You searched for "safety"
Subthreshold micropulse laser in BRVO
1 August 2019
| Saruban Pasu
|
EYE - Vitreo-Retinal
The purpose of this retrospective, consecutive, single-centre, non-randomised, and case-control study was to verify the therapeutic effects and safety of oedema (from branch retinal vein occlusion (BRVO)) recurrence suppression effect using 577-nm subthreshold micropulse laser photocoagulation (SMLP) in combination with...
Long way up
3 February 2023
| Francis Sanders
|
EYE - Cataract, EYE - Glaucoma, EYE - Cornea, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
In the first of a series of guest editorials exploring multiple different Learning Curves, Francis Sanders ruminates on motorcycling and environmental guilt. As an avid motorcyclist, I was naturally drawn to the relatively recent sequel series from Ewan McGregor and...
Wrong intraocular lens events – what lessons have we learned?
Data from wrong IOL patient safety incidents (PSIs) submitted to the National Reporting and Learning System (2010–2014) were reviewed and scrutinised by thematic analysis and compared with the historical data collected for groups in 2003-2010, prior to the mandatory checklist...
Using a driving simulator to explore the effect of visual field loss from optic disc drusen
3 April 2023
| Claire Howard
|
EYE - Neuro-ophthalmology
|
Traffic medicine, driving licence, legislation, optic disc drusen, visual field loss
The purpose of this study was to compare driving simulator performance of participants with visual field loss (VFL) from optic disc drusen (ODD) with a normally sighted control group and a group of individuals with glaucoma. Data on performance and...
Chloral hydrate sedation
1 August 2018
| Jonathan Chan
|
Paediatric Ophthalmology / Strabismus
|
Child health (paediatrics), Drugs
A systematic review of literature sourced from PubMed, EMBASE, ISI, Web of Science, Scopus, CENTRAL, Google Scholar and Trip database to 1 October 2015, about the safety and efficacy of chloral hydrate (CH) by meta-analysis of randomised controlled trials (RCTs)...
Topical atorvastatin for dry eye and blepharitis
Dry eye is a very common problem with 20% of the population affected and is frequently associated with blepharitis (DEB), which has an over prevalence of about 40%. The aim of this study was to evaluate a topical atorvastatin formulation...Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
29 March 2023
|
glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.
Unaddressed Vision Problems Linked to Many Bus Crashes in Bangladesh, Study Finds
7 April 2022
The new research from eye care nonprofit Orbis International is among the first to look at vision and road safety among public transportation workers in low- and middle-income countries.
National sight loss charity calls for street credibility
Urgent action must be taken to improve street design and accessibility for blind and partially sighted pedestrians says the Royal National Institute of Blind People (RNIB) Scotland in their latest report, ‘Street Credibility’.Sight loss charities slam Scottish government for making blind and partially sighted people play tactile paving roulette
14 February 2024
|
Sight Scotland, Sight Scotland Veterans, Government, ministry of transport, scotland
Sight Scotland launches ‘Pave the Way’ campaign to have tactile paving installed in every train station in Scotland.
How good does my vision have to be to drive this thing? Visual standards for various occupations
2 August 2022
| Myles Potter
|
EYE - General
We can all picture that moment in clinic: you are about to tell someone that they’re no longer legally able to drive, ready to deploy our ‘breaking bad news’ techniques. For some patients this may have been expected, or they...
Moorfields to start new retinal detachment clinical trial
8 November 2023
|
Moorfields, Funding, Phase I trial, Mahi Muqit, retinal detachment, proliferative vitreoretinopathy
Moorfields to start new retinal detachment clinical trial following £1.2 million MRC DPFS grant awarded to UCL and Moorfields Eye Hospital.
